Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating

NAActive, not recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 23, 2017

Primary Completion Date

January 14, 2025

Study Completion Date

January 14, 2025

Conditions
Lung Cancer Stage ILung Cancer Stage IILung Cancer, Nonsmall CellLung Cancer RecurrentLung Cancer Stage IV
Interventions
DEVICE

Real-Time Position Transponder Beacons

The anchored lung tracking beacons are passive electromagnetic transponder beacons which are placed immediately adjacent to a lung tumor using a bronchoscope. Three beacons will be placed in the small airways of the lung adjacent to the target tumor (within 3 cm of the tumor). Each beacon measures 2 mm in diameter and 8 mm in length and consists of a miniature electrical circuit that is encapsulated in a biocompatible glass capsule. Each beacon has an affixed five-legged anchoring system which expands to 5mm diameter once deployed. The Calypso transponder beacon is placed endobronchially using the working channel of a bronchoscope. Navigational bronchoscopy can be used to pre-plan the optimal location for each beacon to be placed within the airways by using a pre-bronchoscopy CT scan.

Trial Locations (2)

R3E 0V9

CancerCare Manitoba, Winnipeg

R

Health Sciences Center, Winnipeg

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Varian Medical Systems

INDUSTRY

lead

CancerCare Manitoba

OTHER